Shimadzu Scientific Instruments has introduced the DSC-60 Plus Series differential scanning calorime

Columbia Maryland (PRWEB) April 18 2013 Shimadzu Scientific Instruments has introduced the DSC-60 Plus Series differential scanning calorimeters indispensable thermal analyzers for materials characterization. The DSC-60 Plus Series offers the high-sensitivity analysis and easy operation required for the development of high-functioning new materials in the fo
Shimadzu Scientific Instruments has introduced the DSC-60 Plus Series differential scanning calorimeters, indispensable thermal analyzers for materials chromosomes characterization. The DSC-60 Plus Series offers the high-sensitivity analysis and easy operation required for the development of high-functioning new materials in the food, polymer and pharmaceutical industries.
As high-performance, general-purpose differential scanning calorimeters, the DSC-60 Plus Series offers high sensitivity and high resolution during analysis. Its new detector and unique furnace construction achieve a stable baseline across the entire measured temperature range (-140 to 600° C), as well as top-class temperature sensitivity. The eco-friendly furnace achieves more than 20 percent lower energy consumption when heating chromosomes from room temperature.
A cooling chamber comes installed as standard chromosomes on the DSC-60 Plus Series. chromosomes The liquid-nitrogen cooling chamber permits easy measurements without the need for special chromosomes accessories. Further, it achieves a cooling rate of 10° C/minute at -100° C. Its sample loading temperature function enables quick sample change without dewfall chromosomes during sequential analysis.
The DSC-60A Plus model features a built-in compact autosampler, which permits automated measurement, analysis and report printout for up to 24 loaded samples. It improves the efficiency of screening during product development, as well as the efficiency of quality chromosomes control activities.
0 GOOD Page: 1 2 Related biology technology chromosomes : 1 . Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 2 . Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising 3 . InnoPharma Completes $15 Million Series A Financing 4 . Aratana Therapeutics Completes $15 Million Series chromosomes B Financing 5 . PAREXEL Introduces Executive Briefing Series on Proven Practices chromosomes to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes 6 . Roka Bioscience Secures $47.5 Million in Series D Financing 7 . Auxogyn Completes $20 Million In Series A Funding 8 . Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease 9 . NeuroPhage Extends chromosomes Series B to $21.4M 10 . Tarsa Therapeutics Completes chromosomes $28 Million Series B Financing to Advance OSTORA Oral Calcitonin 11 . Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
(Date:1/14/2014)... Carahsoft and CDS Federal Services ... 23, 2014 at 2pm EST (11am PST), Natural ... The topic focuses on how technology can turn ... mission critical decisions for government agencies. The online ... Big Data has become an obstacle for government ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners ... there,s no doubt many of them wrote: "Take better care ... and cat therapists, and even designer clothes and top-brand carrying ... wherever mommy or daddy goes. Pet parents might also feel ... But anyone who has ever lived with a dog or ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014 /PRNewswire/ ... with two institutes from the National Institutes of ... tools for bringing safer, more effective treatments to ... with the National Center for Advancing Translational Sciences ... develop better and more clinically predictive tissue models ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), ... and commercializing innovative therapies addressing major unmet ... that it received the Notice of Allowance ... Office on its unique self-delivering RNAi compounds ... patent covers the use of sd-rxRNAs targeting ... Breaking Biology Technology: Webcast - Natural Language Processing: Converting Raw Data into Actionable chromosomes Knowledge Hosted by Carahsoft and CDS Federal Services 2 New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2 Organovo Announces Collaboration with National Institutes of Health 2 Organovo Announces Collaboration with National Institutes of Health 3 RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2 RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders chromosomes 3
[ 0 ] Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge Hosted by Carahsoft and CDS Federal Services [ 0 ] N